Inhalation Sciences names Pontus Nobréus CEO, replacing Manoush Masarrat
Bitget2026/09/22 13:03- Inhalation Sciences Sweden AB named Pontus Nobréus CEO, effective Oct. 5, 2026, replacing Manoush Masarrat at his request.
- Nobréus previously served as CEO of Redsense Medical and Pro Health Pharma Sweden, with international leadership experience in medtech and life sciences.
- Masarrat will remain with the company until year-end to support the management transition.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Synopsys (SNPS.US) partners with OpenAI to develop AI models for chip design, revenue-sharing model drives stock price up by 7%
On Wednesday, chip design software provider Synopsys (SNPS.US) announced that it has reached a partnership agreement with OpenAI. Both parties will jointly develop AI models for the chip business and share related revenues.
BoJ Summary of Opinions: Member says appropriate to keep raising rates in line with economy, price
Rio Tinto secures Bell Bay aluminum smelter operations till 2031
The British Pound rallies on a UK growth upgrade and gives more than half back
Crypto prices
More
